(Q38530298)

3 September 2017

1 reference

title

Sclerostin and DKK1: new players in renal bone and vascular disease (English)

1 reference

3 September 2017

2

Patrick D'Haese

1 reference

3 September 2017

Pieter Evenepoel

1

1 reference

3 September 2017

Vincent Brandenburg

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

17 June 2015

1 reference

3 September 2017

1 reference

3 September 2017

volume

88

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

235-240

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2015.156

3 September 2017

exact match

0 references

cites work

Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases

1 reference

12 December 2020

Arterial calcification and bone physiology: role of the bone-vascular axis

1 reference

12 December 2020

Clinical utility of serum sclerostin measurements

1 reference

12 December 2020

Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study

1 reference

12 December 2020

Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice

1 reference

12 December 2020

Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.

1 reference

12 December 2020

Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes

1 reference

12 December 2020

High rates of death and hospitalization follow bone fracture among hemodialysis patients

1 reference

12 December 2020

Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness

1 reference

12 December 2020

Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients

1 reference

12 December 2020

Arterial klotho expression and FGF23 effects on vascular calcification and function

1 reference

12 December 2020

TNF-α upregulates sclerostin expression in obese mice fed a high-fat diet

1 reference

12 December 2020

The relation between renal function and serum sclerostin in adult patients with CKD.

1 reference

12 December 2020

Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study

1 reference

12 December 2020

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease

1 reference

12 December 2020

The regulation of valvular and vascular sclerosis by osteogenic morphogens

1 reference

12 December 2020

Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?

1 reference

12 December 2020

Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals

1 reference

12 December 2020

WNT signaling in bone homeostasis and disease: from human mutations to treatments

1 reference

12 December 2020

Sclerostin: Another vascular calcification inhibitor?

1 reference

12 December 2020

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

1 reference

12 December 2020

Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study

1 reference

12 December 2020

Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

1 reference

12 December 2020

Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

1 reference

12 December 2020

Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels: the STRAMBO study.

1 reference

12 December 2020

Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification

1 reference

12 December 2020

Abdominal aortic calcification, BMD, and bone microstructure: a population-based study.

1 reference

12 December 2020

Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders

1 reference

12 December 2020

In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation.

1 reference

12 December 2020

Sclerostin and Dickkopf-1 in renal osteodystrophy

1 reference

12 December 2020

Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.

1 reference

12 December 2020

Renal elimination of sclerostin increases with declining kidney function

1 reference

12 December 2020

Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients

1 reference

12 December 2020

Sclerostin blood levels before and after kidney transplantation

1 reference

12 December 2020

Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients

1 reference

12 December 2020

Serum sclerostin is an independent predictor of mortality in hemodialysis patients

1 reference

12 December 2020

Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women

1 reference

12 December 2020

Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium

1 reference

12 December 2020

The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women

1 reference

12 December 2020

Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy

1 reference

12 December 2020

High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study

1 reference

12 December 2020

Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells

1 reference

12 December 2020

Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study

1 reference

12 December 2020

Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients

1 reference

12 December 2020

High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression

1 reference

12 December 2020

The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells

1 reference

12 December 2020

CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder

1 reference

12 December 2020

The three-year incidence of fracture in chronic kidney disease.

1 reference

12 December 2020

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

1 reference

12 December 2020

Romosozumab in postmenopausal women with low bone mineral density.

1 reference

12 December 2020

Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans

1 reference

12 December 2020

Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?

1 reference

12 December 2020

Low bone volume--a risk factor for coronary calcifications in hemodialysis patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/KI.2015.156

1 reference

Dimensions Publication ID

3 September 2017

1038582733

0 references

1 reference